7/107 sources · 6 publishersUpdated Oct 27, 21:42 UTC
Stryker completes acquisition of ZuriMED, adding FiberLocker rotator cuff technology
Stryker announced that it closed its purchase of privately held ZuriMED Technologies AG on October 26, 2026. The deal brings ZuriMED’s FiberLocker System, a 510(k)-cleared rotator cuff augmentation device, into Stryker’s Sports Medicine and shoulder product lines. Stryker said the acquisition expands its ability to support shoulder surgeons across sports medicine and arthroplasty.
Why it matters
The addition of the FiberLocker System broadens Stryker’s shoulder portfolio, giving it a new product in a fast‑growing rotator‑cuff market and potentially driving higher sales in sports‑medicine and shoulder care segments.
Key facts
- 1Stryker completed the acquisition of ZuriMED Technologies AG on October 26, 2026. securities.io
- 2The acquisition adds the FiberLocker System, a rotator cuff augmentation technology, to Stryker’s Sports Medicine portfolio. securities.io
- 3The FiberLocker System received FDA 510(k) clearance on December 11, 2024. securities.io
- 4Financial terms of the transaction were not disclosed. securities.io
- 5Andy Pierce, Group President, MedSurg and Neurotechnology at Stryker, said the deal expands the company’s shoulder care capabilities. securities.io
- 6ZuriMED is a privately held developer of the FiberLocker System based in Zurich, Switzerland. securities.io
Summary written by AlphAI AI Desk from 7 of 7 sources. Not investment advice. Figures are as stated by the linked sources.